Twin Tree Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-5,041
Closed -$8.31M 1232
2019
Q2
$8.31M Buy
5,041
+3,783
+301% +$6.54M 0.04% 338
2019
Q1
$2.56M Buy
1,258
+1,212
+2,635% +$2.13M 0.01% 614
2018
Q4
$60K Sell
46
-734
-94% -$1.13M ﹤0.01% 1119
2018
Q3
$1.48M Sell
780
-1,559
-67% -$3.22M 0.01% 651
2018
Q2
$4.76M Sell
2,339
-548
-19% -$1.25M 0.03% 437
2018
Q1
$6.39M Sell
2,887
-2,401
-45% -$6.11M 0.05% 294
2017
Q4
$12.2M Buy
+5,288
New +$10.7M 0.09% 190

Other funds holding BLUE

Twin Tree Management's BLUE Position: Q3 2019 in Review

Twin Tree Management sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 744 shares — an estimated $1.23M sold.

Twin Tree Management first reported a position in BLUE in Q4 2017 and held it in 7 quarters. The position peaked at $1.74M in Q2 2018. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

  • Twin Tree Management reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
  • Twin Tree Management sold 744 bluebird bio shares in Q3 2019, an estimated $1.23M.
  • Twin Tree Management first reported a position in bluebird bio in Q4 2017 and held it in 7 quarters.
  • Twin Tree Management's bluebird bio position peaked at $1.74M in Q2 2018.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Twin Tree Management's 13F filing for Q3 2019, filed 12 Nov 2019.